SageTech Medical Awarded £3.6 Million from Innovate UK's 'Grand Challenge' Programme

PAIGNTON, U.K. - EntSun -- A consortium lead by SageTech Medical, a pioneering UK-based company developing sustainable technologies for the healthcare sector, has been awarded £3.6 million in grant funding through Innovate UK's Grand Challenge. The consortium members are The Manufacturing Technology Centre, The Centre for Process Innovation, Royal Devon University Healthcare NHS Foundation Trust and The University of Plymouth.

This award follows the company's earlier success in the Expression of Interest (EoI) stage of the Sustainable Medicines Manufacturing Innovation Programme (SMMIP), an initiative designed to drive innovation and sustainability across the UK's life sciences manufacturing sector. The SMMIP EoI competition provided seed funding to help organisations form consortia and prepare proposals for future Grand Challenges - large-scale collaborative R&D awards worth up to £10 million per project. By supporting collaboration between academia, industry, and healthcare providers, Innovate UK's SMMIP aims to build a sustainable and resilient UK manufacturing base capable of delivering greener, smarter healthcare technologies.

More on EntSun News

• Jon Robert Quinn: The Visionary Behind a Growing Independent Media Empire
• Attn: Singers, Musicians, Music Producers & Record Companies: Looking for your Next Big Song Hits?
• Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
• $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
• High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030

This commitment to sustainable innovation aligns directly with SageTech Medical's mission to reduce the environmental impact of healthcare, particularly through tackling the climate challenge posed by anaesthetic gases.

A large proportion of the anaesthetic gases used during surgery are not metabolised by patients and are instead exhaled into the atmosphere. These gases, which include sevoflurane, isoflurane, and desflurane, are potent greenhouse agents that remain in the atmosphere for long periods, contributing significantly to global warming. Worldwide, the atmospheric disposal of volatile anaesthetic gases account for approximately four million tonnes of CO₂ equivalent emissions each year.  It is estimated that the manufacture of volatile anaesthetics adds up to an additional two and a half million tonnes, with existing waste management systems contributing a further estimated one and a quarter million tonnes, altogether making them a notable contributor to the carbon footprint of healthcare systems.

More on EntSun News

• Top10Christmas.co.uk Releases the UK Christmas Toy Trends 2025 Report
• Talagat Business Academy Announces Joint Certificate Program With The University of Chicago Booth School of Business
• LocaXion and Asseco CEIT Announce First-to-Market RTLS-Driven Digital Twin Platform for Healthcare, Manufacturing, and Logistics
• Slotozilla Launches New Report on How AI Is Reshaping Careers and Society
• Really Cool Music Announces That Its Debut Single "I Move In Silence" Has Been Streamed Around the World

SageTech Medical has developed an innovative circular solution that captures, recovers, and recycles these waste gases. Its reusable SID-Can filters safely capture the waste anaesthetic during procedures and are then returned to SageTech for agent recovery and recycling, where it is converted back into usable anaesthetics for reuse in hospitals, creating a circular economy system.

The £3.6 million Grand Challenge funding will enable SageTech Medical to expand manufacturing capacity and increase production of its patented recycling systems to meet growing demand in the UK and abroad. The company will also develop new data-driven technologies for sustainable gas recovery and reuse, while improving energy efficiency and reducing waste across its entire production process.

Read full press release at News & Events | SageTech Medical (https://www.sagetechmedical.com/news-events/)